Copyright Reports & Markets. All rights reserved.

Global Oncolytic Virus Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Oncolytic Virus Therapy Market Overview

    • 1.1 Product Overview and Scope of Oncolytic Virus Therapy
    • 1.2 Classification of Oncolytic Virus Therapy by Type
      • 1.2.1 Global Oncolytic Virus Therapy Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Type in 2019
      • 1.2.3 HSV-based Oncolytic Viruses
      • 1.2.4 Adenoviruses-based Oncolytic Viruses
      • 1.2.5 Vaccinia Virus-based Oncolytic Viruses
      • 1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses
      • 1.2.7 Newcastle Disease Virus-based Oncolytic Viruses
    • 1.3 Global Oncolytic Virus Therapy Market by Application
      • 1.3.1 Overview: Global Oncolytic Virus Therapy Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Melanoma
      • 1.3.3 Prostate Cancer
      • 1.3.4 Breast Cancer
      • 1.3.5 Ovarian Cancer
      • 1.3.6 Others
    • 1.4 Global Oncolytic Virus Therapy Market by Regions
      • 1.4.1 Global Oncolytic Virus Therapy Market Size by Regions: 2015 VS 2019 VS 2025
      • 1.4.2 Global Market Size of Oncolytic Virus Therapy (2015-2025)
      • 1.4.3 North America (USA, Canada and Mexico) Oncolytic Virus Therapy Status and Prospect (2015-2025)
      • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Therapy Status and Prospect (2015-2025)
      • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Therapy Status and Prospect (2015-2025)
      • 1.4.6 South America (Brazil, Argentina, Colombia) Oncolytic Virus Therapy Status and Prospect (2015-2025)
      • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Therapy Status and Prospect (2015-2025)

    2 Company Profiles

    • 2.1 Amgen
      • 2.1.1 Amgen Details
      • 2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Amgen SWOT Analysis
      • 2.1.4 Amgen Product and Services
      • 2.1.5 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 SillaJen Biotherapeutics
      • 2.2.1 SillaJen Biotherapeutics Details
      • 2.2.2 SillaJen Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 SillaJen Biotherapeutics SWOT Analysis
      • 2.2.4 SillaJen Biotherapeutics Product and Services
      • 2.2.5 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Transgene SA
      • 2.3.1 Transgene SA Details
      • 2.3.2 Transgene SA Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Transgene SA SWOT Analysis
      • 2.3.4 Transgene SA Product and Services
      • 2.3.5 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Oncolytics Biotech
      • 2.4.1 Oncolytics Biotech Details
      • 2.4.2 Oncolytics Biotech Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Oncolytics Biotech SWOT Analysis
      • 2.4.4 Oncolytics Biotech Product and Services
      • 2.4.5 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 PsiOxus Therapeutics
      • 2.5.1 PsiOxus Therapeutics Details
      • 2.5.2 PsiOxus Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 PsiOxus Therapeutics SWOT Analysis
      • 2.5.4 PsiOxus Therapeutics Product and Services
      • 2.5.5 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Viralytics
      • 2.6.1 Viralytics Details
      • 2.6.2 Viralytics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Viralytics SWOT Analysis
      • 2.6.4 Viralytics Product and Services
      • 2.6.5 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Lokon Pharma
      • 2.7.1 Lokon Pharma Details
      • 2.7.2 Lokon Pharma Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Lokon Pharma SWOT Analysis
      • 2.7.4 Lokon Pharma Product and Services
      • 2.7.5 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Targovax
      • 2.8.1 Targovax Details
      • 2.8.2 Targovax Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Targovax SWOT Analysis
      • 2.8.4 Targovax Product and Services
      • 2.8.5 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Oncolys BioPharma
      • 2.9.1 Oncolys BioPharma Details
      • 2.9.2 Oncolys BioPharma Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Oncolys BioPharma SWOT Analysis
      • 2.9.4 Oncolys BioPharma Product and Services
      • 2.9.5 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Sorrento Therapeutics
      • 2.10.1 Sorrento Therapeutics Details
      • 2.10.2 Sorrento Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Sorrento Therapeutics SWOT Analysis
      • 2.10.4 Sorrento Therapeutics Product and Services
      • 2.10.5 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 Genelux Corporation
      • 2.11.1 Genelux Corporation Details
      • 2.11.2 Genelux Corporation Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 Genelux Corporation SWOT Analysis
      • 2.11.4 Genelux Corporation Product and Services
      • 2.11.5 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 Cold Genesys
      • 2.12.1 Cold Genesys Details
      • 2.12.2 Cold Genesys Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 Cold Genesys SWOT Analysis
      • 2.12.4 Cold Genesys Product and Services
      • 2.12.5 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.13 Vyriad
      • 2.13.1 Vyriad Details
      • 2.13.2 Vyriad Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.13.3 Vyriad SWOT Analysis
      • 2.13.4 Vyriad Product and Services
      • 2.13.5 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)
    • 2.14 TILT Biotherapeutics
      • 2.14.1 TILT Biotherapeutics Details
      • 2.14.2 TILT Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.14.3 TILT Biotherapeutics SWOT Analysis
      • 2.14.4 TILT Biotherapeutics Product and Services
      • 2.14.5 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    • 3.1 Global Oncolytic Virus Therapy Revenue and Share by Players (2015-2020)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Oncolytic Virus Therapy Players Market Share
      • 3.2.2 Top 10 Oncolytic Virus Therapy Players Market Share
    • 3.3 Market Competition Trend

    4 Market Size by Regions

    • 4.1 Global Oncolytic Virus Therapy Revenue and Market Share by Regions
    • 4.2 North America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 4.3 Europe Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 4.5 South America Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 4.6 Middle East & Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

    5 North America Oncolytic Virus Therapy Revenue by Countries

    • 5.1 North America Oncolytic Virus Therapy Revenue by Countries (2015-2020)
    • 5.2 USA Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 5.3 Canada Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 5.4 Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

    6 Europe Oncolytic Virus Therapy Revenue by Countries

    • 6.1 Europe Oncolytic Virus Therapy Revenue by Countries (2015-2020)
    • 6.2 Germany Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 6.3 UK Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 6.4 France Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 6.5 Russia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 6.6 Italy Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

    7 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries

    • 7.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries (2015-2020)
    • 7.2 China Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 7.3 Japan Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 7.4 Korea Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 7.5 India Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

    8 South America Oncolytic Virus Therapy Revenue by Countries

    • 8.1 South America Oncolytic Virus Therapy Revenue by Countries (2015-2020)
    • 8.2 Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 8.3 Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

    9 Middle East & Africa Revenue Oncolytic Virus Therapy by Countries

    • 9.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Countries (2015-2020)
    • 9.2 Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 9.3 UAE Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 9.4 Egypt Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)
    • 9.5 South Africa Oncolytic Virus Therapy Revenue and Growth Rate (2015-2020)

    10 Market Size Segment by Type

    • 10.1 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2015-2020)
    • 10.2 Global Oncolytic Virus Therapy Market Forecast by Type (2019-2024)
    • 10.3 HSV-based Oncolytic Viruses Revenue Growth Rate (2015-2025)
    • 10.4 Adenoviruses-based Oncolytic Viruses Revenue Growth Rate (2015-2025)
    • 10.5 Vaccinia Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)
    • 10.6 Vesicular Stomatitis Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)
    • 10.7 Newcastle Disease Virus-based Oncolytic Viruses Revenue Growth Rate (2015-2025)

    11 Global Oncolytic Virus Therapy Market Segment by Application

    • 11.1 Global Oncolytic Virus Therapy Revenue Market Share by Application (2015-2020)
    • 11.2 Oncolytic Virus Therapy Market Forecast by Application (2019-2024)
    • 11.3 Melanoma Revenue Growth (2015-2020)
    • 11.4 Prostate Cancer Revenue Growth (2015-2020)
    • 11.5 Breast Cancer Revenue Growth (2015-2020)
    • 11.6 Ovarian Cancer Revenue Growth (2015-2020)
    • 11.7 Others Revenue Growth (2015-2020)

    12 Global Oncolytic Virus Therapy Market Size Forecast (2021-2025)

    • 12.1 Global Oncolytic Virus Therapy Market Size Forecast (2021-2025)
    • 12.2 Global Oncolytic Virus Therapy Market Forecast by Regions (2021-2025)
    • 12.3 North America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)
    • 12.4 Europe Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)
    • 12.5 Asia-Pacific Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)
    • 12.6 South America Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)
    • 12.7 Middle East & Africa Oncolytic Virus Therapy Revenue Market Forecast (2021-2025)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology
      • 14.2 Data Source
      • 14.3 Disclaimer

      Summary

      Market Overview
      The global Oncolytic Virus Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 23.8% in the forecast period of 2020 to 2025 and will expected to reach USD 9 million by 2025, from USD 4 million in 2019.
      The Oncolytic Virus Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

      Market segmentation
      Oncolytic Virus Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
      By Type, Oncolytic Virus Therapy market has been segmented into HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses, etc.
      By Application, Oncolytic Virus Therapy has been segmented into Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others, etc.
      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncolytic Virus Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncolytic Virus Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncolytic Virus Therapy market.
      The report offers in-depth assessment of the growth and other aspects of the Oncolytic Virus Therapy market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Oncolytic Virus Therapy markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
      Competitive Landscape and Oncolytic Virus Therapy Market Share Analysis
      Oncolytic Virus Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncolytic Virus Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncolytic Virus Therapy sales, revenue and market share for each player covered in this report.
      The major players covered in Oncolytic Virus Therapy are: Amgen, SillaJen Biotherapeutics, Transgene SA, Oncolytics Biotech, PsiOxus Therapeutics, Viralytics, Lokon Pharma, Targovax, Oncolys BioPharma, Sorrento Therapeutics, Genelux Corporation, Cold Genesys, Vyriad, TILT Biotherapeutics, etc. Among other players domestic and global, Oncolytic Virus Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

      Buy now